Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ENvue Medical (formerly NanoVibronix) is a commercial-stage medical technology company specializing in non-invasive therapeutic devices and enteral feeding navigation systems. The company's core product portfolio includes UroShield, a wearable ultrasound device designed to prevent catheter-associated urinary tract infections (CAUTIs) and biofilm formation, and PainShield, a therapeutic ultrasound device for pain management. Additionally, following its 2025 merger with ENvue Medical Holdings, the company operates the ENvue Navigation Platform, an electromagnetic navigation system that assists clinicians in placing enteral feeding tubes. ENvue Medical is publicly traded on the NASDAQ under the ticker symbol FEED.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UroShield.